NANBING LI-VILLARREAL to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications NANBING LI-VILLARREAL has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.997
-
Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 11 15; 24(22):5744-5756.
Score: 0.442
-
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res. 2018 01 15; 24(2):341-350.
Score: 0.418
-
High-Content Clonogenic Survival Screen to Identify Chemoradiation Sensitizers. Int J Radiat Oncol Biol Phys. 2021 12 01; 111(5):e27-e37.
Score: 0.136